Sanofi invests €170 million in new vaccine production facility in France
Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France.
October 12, 2017
Sanofi updates information on dengue vaccine
New analysis of long-term Dengvaxia® data found differences in vaccine performance based on prior dengue infection.
November 29, 2017
About 3 million
lives saved in the world every year thanks to vaccination
Immunization: discover all our actions in the world